标题
Immunotherapy against cancer-related viruses
作者
关键词
-
出版物
CELL RESEARCH
Volume 27, Issue 1, Pages 59-73
出版商
Springer Nature
发表日期
2016-12-25
DOI
10.1038/cr.2016.153
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hepatitis B and cancer: A practical guide for the oncologist
- (2016) Claudia Bozza et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Combinatorial immunotherapy strategies for hepatocellular carcinoma
- (2016) Maria Tagliamonte et al. CURRENT OPINION IN IMMUNOLOGY
- Prospects for gene-engineered T cell immunotherapy for solid cancers
- (2016) Christopher A Klebanoff et al. NATURE MEDICINE
- Global burden of cancers attributable to infections in 2012: a synthetic analysis
- (2016) Martyn Plummer et al. Lancet Global Health
- Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination
- (2016) Anna Louise Beavis et al. Frontiers in Oncology
- Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans
- (2015) L. I. Backus et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6
- (2015) L. M. Draper et al. CLINICAL CANCER RESEARCH
- Safety of human papillomavirus vaccines: a review
- (2015) Michela Stillo et al. Expert Opinion On Drug Safety
- Immunotherapeutic Approaches for the Control and Eradication of HIV
- (2015) Daniel Amsterdam IMMUNOLOGICAL INVESTIGATIONS
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs
- (2015) Seok-Goo Cho et al. MOLECULAR THERAPY
- Success and failure of the cellular immune response against HIV-1
- (2015) Stephen A Migueles et al. NATURE IMMUNOLOGY
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age
- (2015) Ting-Xun Lu et al. Scientific Reports
- Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus
- (2015) Natalie Kash et al. Journal of Clinical Medicine
- Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells
- (2014) I. Ricciardelli et al. BLOOD
- The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: A comprehensive and evidence-based comparison and review
- (2014) Zhi Ven Fong et al. CANCER
- Human Viral Oncogenesis: A Cancer Hallmarks Analysis
- (2014) Enrique A. Mesri et al. Cell Host & Microbe
- A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
- (2014) G. S. Taylor et al. CLINICAL CANCER RESEARCH
- The role of sexual behavior in head and neck cancer: implications for prevention and therapy
- (2014) Eleni Rettig et al. Expert Review of Anticancer Therapy
- Antiviral T-cell therapy
- (2014) Ann M. Leen et al. IMMUNOLOGICAL REVIEWS
- Complementation of Antigen-presenting Cells to Generate T Lymphocytes With Broad Target Specificity
- (2014) Minhtran Charlotte Ngo et al. JOURNAL OF IMMUNOTHERAPY
- The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets
- (2014) Marc Ringelhan et al. JOURNAL OF PATHOLOGY
- The role of Epstein-Barr virus in epithelial malignancies
- (2014) Sai-Wah Tsao et al. JOURNAL OF PATHOLOGY
- Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor
- (2014) Ann M Leen et al. MOLECULAR THERAPY
- Epigenetic Manipulation Restores Functions of Defective CD8+ T Cells From Chronic Viral Infection
- (2014) Fuqin Zhang et al. MOLECULAR THERAPY
- Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT
- (2014) A. Papadopoulou et al. Science Translational Medicine
- Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
- (2014) Tae Jin Kim et al. Nature Communications
- A meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinoma
- (2014) Xiaofeng Li et al. Clinics and Research in Hepatology and Gastroenterology
- Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
- (2013) A. M. Leen et al. BLOOD
- Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
- (2013) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- Challenges in cancer vaccine development for hepatocellular carcinoma
- (2013) Luigi Buonaguro et al. JOURNAL OF HEPATOLOGY
- Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant
- (2013) Ulrike Gerdemann et al. MOLECULAR THERAPY
- Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
- (2013) Whay-Kuang Chia et al. MOLECULAR THERAPY
- The pathogenesis of Epstein–Barr virus persistent infection
- (2013) David A Thorley-Lawson et al. Current Opinion in Virology
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
- (2012) Tim F Greten et al. BMC CANCER
- Cytokine-induced killer cells in the treatment of patients with solid carcinomas: a systematic review and pooled analysis
- (2012) Yue Ma et al. CYTOTHERAPY
- Human Papillomavirus Type 16 E6/E7-specific Cytotoxic T Lymphocytes for Adoptive Immunotherapy of HPV-associated Malignancies
- (2012) Carlos A. Ramos et al. JOURNAL OF IMMUNOTHERAPY
- T-cell therapy in the treatment of post-transplant lymphoproliferative disease
- (2012) Catherine M. Bollard et al. Nature Reviews Clinical Oncology
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Merkel cell polyomavirus: A newly discovered human virus with oncogenic potential
- (2012) Megan E. Spurgeon et al. VIROLOGY
- Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
- (2012) Hisashi Iizasa et al. Viruses-Basel
- Immunotherapy of hepatocellular carcinoma
- (2012) Angela D. Pardee et al. OncoImmunology
- T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results
- (2011) S. Secondino et al. ANNALS OF ONCOLOGY
- Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
- (2011) E. Doubrovina et al. BLOOD
- Immune defence against EBV and EBV-associated disease
- (2011) Heather M Long et al. CURRENT OPINION IN IMMUNOLOGY
- The PD-1/PD-L1 (B7-H1) Pathway in Chronic Infection-Induced Cytotoxic T Lymphocyte Exhaustion
- (2011) Kimberly A. Hofmeyer et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Combining mTor Inhibitors With Rapamycin-resistant T Cells: A Two-pronged Approach to Tumor Elimination
- (2011) Leslie E Huye et al. MOLECULAR THERAPY
- Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer
- (2011) D R McGivern et al. ONCOGENE
- Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
- (2011) J. I. Cohen et al. Science Translational Medicine
- Immunobiology of Merkel Cell Carcinoma: Implications for Immunotherapy of a Polyomavirus-Associated Cancer
- (2011) Shailender Bhatia et al. Current Oncology Reports
- Vaccines to Prevent Infections by Oncoviruses
- (2010) John T. Schiller et al. Annual Review of Microbiology
- Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
- (2010) J. N. Barker et al. BLOOD
- Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells
- (2010) A. Moosmann et al. BLOOD
- Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma
- (2010) Chrystal U. Louis et al. JOURNAL OF IMMUNOTHERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy
- (2010) M Matsuoka et al. ONCOGENE
- Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)
- (2009) B. De Angelis et al. BLOOD
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation
- (2009) Michael Uhlin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Role of the Epstein–Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma
- (2009) Mhairi A Morris et al. Future Oncology
- Genetic Manipulation of Tumor-specific Cytotoxic T Lymphocytes to Restore Responsiveness to IL-7
- (2009) Juan F Vera et al. MOLECULAR THERAPY
- Human tumor-associated viruses and new insights into the molecular mechanisms of cancer
- (2009) D Martin et al. ONCOGENE
- Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma
- (2009) M. H. Fogg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation
- (2009) Lesley Rees et al. TRANSPLANTATION
- Papillomaviruses in the causation of human cancers — a brief historical account
- (2009) Harald zur Hausen VIROLOGY
- Mechanism of Genomic Instability in Cells Infected with the High-Risk Human Papillomaviruses
- (2009) Meelis Kadaja et al. PLoS Pathogens
- The Dynamics of EBV Shedding Implicate a Central Role for Epithelial Cells in Amplifying Viral Output
- (2009) Vey Hadinoto et al. PLoS Pathogens
- Immunotherapy targeting EBV-expressing lymphoproliferative diseases
- (2008) Catherine M. Bollard et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- The History of Tumor Virology
- (2008) R. T. Javier et al. CANCER RESEARCH
- Infections and cancer: Established associations and new hypotheses
- (2008) Catherine de Martel et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- EBV-Associated Lymphoproliferative Disorders: Classification and Treatment
- (2008) A. Carbone et al. ONCOLOGIST
- Epstein-Barr virus: a paradigm for persistent infection – for real and in virtual reality
- (2008) David A. Thorley-Lawson et al. TRENDS IN IMMUNOLOGY
- Viruses associated with human cancer
- (2007) Margaret E. McLaughlin-Drubin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- T cell therapy of Epstein–Barr virus and adenovirus infections after hemopoietic stem cell transplant
- (2007) P. Comoli et al. BLOOD CELLS MOLECULES AND DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started